[1]
|
Kristin, S. and Mara, S. (2022) The Concept of Rheumatoid Arthritis (RA). Journal of Contemporary Medical Practice, 4.
|
[2]
|
Greenblatt, H.K., Kim, H.A., Bettner, L.F., et al. (2020) Preclinical Rheumatoid Arthritis and Rheumatoid Arthri-tis Prevention. Current Opinion in Rheumatology, 32, 289-296. https://doi.org/10.1097/BOR.0000000000000708
|
[3]
|
Prasad, P., Verma, S., et al. (2022) Rheumatoid Arthritis: Advances in Treatment Strategies. Molecular and Cellular Biochemistry, 478, 69-88. https://doi.org/10.1007/s11010-022-04492-3
|
[4]
|
Guerra, J.D., De, S.A.B., Reed, S., et al. (2022) Cardiology Co-Management of Rheumatoid Arthritis Patients with Coronary Artery Disease as an Intervention Reduces Hospitaliza-tion Rates and Adverse Event Occurrence. Clinical Rheumatology, 41, 3715-3724. https://doi.org/10.1007/s10067-022-06335-4
|
[5]
|
Jin, S.Y., Zhao, J.L., Li, M.T., et al. (2022) New Insights into the Pathogenesis and Management of Rheumatoid Arthritis. Chronic Diseases and Translational Medicine, 8, 256-263. https://doi.org/10.1002/cdt3.43
|
[6]
|
Chen, J., He, Z., Fan, Y., et al. (2020) Production of a Bispecific Antibody Targeting TNF-a and C5a in Pichia pastoris and Its Therapeutic Potential in Rheumatoid Arthritis. Biotechnology Letters, 42, 557-569.
https://doi.org/10.1007/s10529-020-02830-3
|
[7]
|
Samantha, B., Joshua, B., Alex, K., et al. (2018) Emergent Com-plications of Rheumatoid Arthritis. Journal of Emergency Medicine, 55, 647-658. https://doi.org/10.1016/j.jemermed.2018.07.030
|
[8]
|
Wang, M., Zhang, L., Peng, Z., et al. (2020) A Survey on Therapy Strategies for Rheumatoid Arthritis in Chinese Rheumatologists. Chinese Journal of Internal Medicine, 59, 375-379.
|
[9]
|
Bywall, K.S., Esbensen, B.A., Lason, M., et al. (2022) Functional Capacity vs Side Effects: Treatment Attributes to Consider When Individualising Treatment for Patients with Rheumatoid Arthritis. Clinical Rheumatology, 41, 695-704.
https://doi.org/10.1007/s10067-021-05961-8
|
[10]
|
熊江华, 李艳. 中药复方对类风湿性关节炎炎干预机制的研究进展[J]. 中国实验方剂学杂志, 2017, 23(9): 230-234.
|
[11]
|
马悦宁. 从“双毒学说”论治类风湿关节炎学术思想总结及临床研究[D]: [硕士学位论文]. 天津: 天津中医药大学, 2021.
|
[12]
|
Zhang, H.M. (2019) Standardized Diag-nosis-Therapy and Stepwise Treatment for Knee Osteoarthritis. China Journal of Orthopaedics and Traumatology, 32, 391-395.
|
[13]
|
王妍曦, 桑希生. 基于《黄帝内经》对“痹”内涵及痹病分类的认识[J]. 中国中医基础医学杂志, 2021, 27(6): 916-917+1010.
|
[14]
|
王帆帆, 刘健, 方妍妍, 等. 中药治疗类风湿关节炎血瘀证的文献数据挖掘和Meta分析[J]. 风湿病与关节炎, 2022, 11(7): 31-37+46.
|
[15]
|
蔡燕萍, 徐静. 遵循中医消托补原则配合适宜技术完善骨科疾病管理[J]. 中医药管理杂志, 2022, 30(19): 165-167.
|
[16]
|
王晓翠. 基于温病湿热理论的代谢综合征相关性研究[D]: [博士学位论文]. 济南: 山东中医药大学, 2021.
|
[17]
|
于鹰, 李玉清. 张灿玾临证方药运用经验[J]. 山东中医药大学学报, 2019, 43(2): 111-114.
|
[18]
|
张林华. 基于数据挖掘的中医治疗风湿病临床用药规律与作用机制研究[D]: [硕士学位论文]. 北京: 北京中医药大学, 2019.
|
[19]
|
徐润, 姜泉, 韩曼. 五脏痹理论在类风湿性关节炎多系统受累中的应用探讨[J]. 云南中医中药杂志, 2022, 43(9): 14-19.
|
[20]
|
李琇莹, 朱琦. 中药复方治疗类风湿关节炎应用网络药理学的研究进展[J]. 中华中医药学刊, 2022, 7(22): 1673-7717.
|
[21]
|
韩宇飞, 高明利, 刘东武. 类风湿性关节炎的发病机制研究进展综述[J]. 中国卫生标准管理, 2021, 12(1): 162-165.
|
[22]
|
许文亚, 刘秋红, 李晓茹. 类风湿关节炎从虚论治[J]. 中外医疗2016, 35(34): 195-198.
|
[23]
|
王文越, 刘珊, 吕琴, 等. 黄芪-当归药对益气活血药理作用研究进展[J]. 中国实验方剂学杂志, 2021, 27(6): 207-216.
|
[24]
|
赵霞. 银花甘草汤联合康复新液外治直肠癌放疗患者肛周放射性皮炎60例[J]. 浙江中医杂志, 2020, 55(7): 514.
|
[25]
|
Weber, B.Z.C., Agca, S., Domaniku, A., et al. (2022) Inhibition of Epidermal Growth Factor Receptor Suppresses Parathyroid Hor-mone-Related Protein Expression in Tumours and Ameliorates Cancer-Associated Cachexia. Journal of Cachexia, Sar-copenia and Muscle, 13, 1582-1594. https://doi.org/10.1002/jcsm.12985
|
[26]
|
Swanson, C.D., Akama, G.E.H., Stein, E.A., et al. (2012) Inhibition of Epidermal Growth Factor Receptor Tyrosine Kinase Ameliorates Collagen-Induced Arthritis. Journal of Immunology (Baltimore, Md.: 1950), 188, 3513-3521.
https://doi.org/10.4049/jimmunol.1102693
|
[27]
|
王丹丹. 清络饮通过SIRT1干预单核/巨噬细胞极化治疗类风湿性关节炎大鼠模型的机制研究[D]: [硕士学位论文]. 芜湖: 皖南医学院, 2022.
|
[28]
|
Bhosale, P.B., Kim, H.H., Abusaliya, A., et al. (2022) Structural and Functional Properties of Activator Protein-1 in Cancer and Inflammation. Evi-dence-Based Complementary and Alternative Medicine, 2022, Article ID: 9797929.
https://doi.org/10.1155/2022/9797929
|
[29]
|
Huber, R., Augsten, S., Kirsten, H., et al. (2020) Identification of New, Functionally Relevant Mutations in the Coding Regions of the Human Fos and Jun Proto-Oncogenes in Rheumatoid Ar-thritis Synovial Tissue. Life (Basel, Switzerland), 11, Article No. 5. https://doi.org/10.3390/life11010005
|
[30]
|
Shi, L., Zhao, Y.Y., Feng, C.R., et al. (2022) Therapeutic Effects of Shaoganfuzi Decoction in Rheumatoid Arthritis: Network Pharmacology and Experimental Validation. Frontiers in Pharmacology, 13, Article ID: 967164.
https://doi.org/10.3389/fphar.2022.967164
|
[31]
|
Liang, G.C., Duan, W.G., Chen, S.Y., et al. (2021) Analysis of the Composition and Anti-Rheumatoid Arthritis Mechanism of Qintengtongbi Decoction Based on Network Pharmacology. Natural Product Communications, 16.
https://doi.org/10.1177/1934578X211041421
|
[32]
|
吴志颖. 祛风除湿通络方治疗类风湿关节炎的临床疗效及其对JAK2-STAT3信号通路的影响[D]: [硕士学位论文]. 南昌: 江西中医药大学, 2021.
|
[33]
|
刘永芳. 基于JAK1/STAT3信号通路探讨历节胶囊治疗RA作用机制的研究[D]: [硕士学位论文]. 南宁: 广西中医药大学, 2021.
|
[34]
|
Tang, M.S., Zeng, Y., Peng, W.J., et al. (2022) Pharmacological Aspects of Natural Quercetin in Rheuma-toid Arthritis. Drug Design, Development and Therapy, 16, 2043-2053. https://doi.org/10.2147/DDDT.S364759
|
[35]
|
Pan, D.M., Li, N., Liu, Y.Y., et al. (2018) Kaempferol Inhibits the Migration and Invasion of Rheumatoid Arthritis Fibroblast-Like Synoviocytes by Blocking Activation of the MAPK Pathway. International Immunopharmacology, 55, 174-182. https://doi.org/10.1016/j.intimp.2017.12.011
|
[36]
|
Xu, K.D., Miao, Y., Li, P., et al. (2021) Licochalcone A Inhibits Cell Growth through the Downregulation of the Hippo Pathway via PES1 in Cholangiocarcinoma Cells. Environmental Toxicology, 37, 564-573.
https://doi.org/10.1002/tox.23422
|
[37]
|
果彤. 运脾解毒通络祛湿方治疗类风湿关节炎的网络靶标预测及机制初探[D]: [硕士学位论文]. 北京: 北京中医药大学, 2020.
|
[38]
|
刘琼, 李永乐, 董平, 等. PI3K/Akt信号通路与类风湿关节炎相关性探讨[J]. 风湿病与关节炎, 2021, 10(3): 62-66.
|
[39]
|
刘颖. 类风湿关节炎患者动脉粥样硬化危险因素分析及机制探讨[D]: [博士学位论文]. 济南: 山东大学, 2018.
|